Abstract
IntroductionCurrently, there are no biomarkers capable of identifiying those at greatest risk of developing Parkinson's disease dementia (PDD). In patients with PDD, magnetic resonance imaging (MRI) demonstrates diffuse grey matter...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
